Advances in the Canine Cranial Cruciate Ligament, 2nd edition

(Wang) #1
Clinical Research Design and Patient-Oriented Outcomes 361

Brown DC. The Canine Orthopaedic Index. Step 3:
Responsiveness testing. Vet Surg 2014c;43:247–254.
Brown DC, Boston RC, Coyne JC,et al. Develop-
ment and psychometric testing of an instrument
designed to measure chronic pain in dogs with
osteoarthritis. Am J Vet Res 2007;68:631–637.
Brown DC, Boston RC, Coyne JC,et al. Ability of the
canine brief pain inventory to detect response to
treatment in dogs with osteoarthritis. J Am Vet Med
Assoc 2008;233:1278–1283.
Brown DC, Bell M, Rhodes L. Power of treatment suc-
cess definitions when the Canine Brief Pain Inven-
tory is used to evaluate carprofen treatment for
the control of pain and inflammation in dogs with
osteoarthritis. Am J Vet Res 2013a;74:1467–1473.
[Erratum appears in Am J Vet Res 2014;75:353].
Brown DC, Boston RC, Farrar JT. Comparison of force
plate gait analysis and owner assessment of pain
using the Canine Brief Pain Inventory in dogs with
osteoarthritis. J Vet Intern Med 2013b;27:22–30.
Davis CE, Applegate WB, Gordon DJ,et al. An empir-
ical evaluation of the placebo run-in. Control Clin
Trials 1995;16:41–50.
Dworkin RH, Turk DC, Peirce-Sandner S,et al.
Considerations for improving assay sensitivity in
chronic pain clinical trials: IMMPACT recommen-
dations. Pain 2012;153:1148–1158.
Fahie MA, Ortolano GA, Guercio V,et al. A random-
ized controlled trial of the efficacy of autologous
platelet therapy for the treatment of osteoarthritis
in dogs. J Am Vet Med Assoc 2013;243:1291–1297.
Furlan A, Chaparro LE, Irvin E,et al. A compar-
ison between enriched and nonenriched enroll-
ment randomized withdrawal trials of opioids
for chronic noncancer pain. Pain Res Manag
2011;16:337–351.
Gordon-Evans WJ, Griffon DJ, Bubb C,et al. Compar-
ison of lateral fabellar suture and tibial plateau lev-
eling osteotomy techniques for treatment of dogs
with cranial cruciate ligament disease. J Am Vet
Med Assoc 2013;243: 675–680. [Erratum appears in
J Am Vet Med Assoc 2013;243:1297].
Hauser W, Bartram-Wunn E, Bartram C, ̈ et al.Sys-
tematic review: Placebo response in drug trials of
fibromyalgia syndrome and painful peripheral dia-
betic neuropathy-magnitude and patient-related
predictors. Pain 2011;152:1709–1717.
Heikkila HM, Heilm-Bj ̈ orkman AK, Morelius M, ̈ et al.
Intra-articular botulinum toxin A for the treat-
ment of osteoarthritic joint pain in dogs: a ran-
domized, double-blinded, placebo-controlled clin-
ical trial. Vet J 2014;200:162–169.
Hercock CA, Pinchback G, Giejda A,et al. Valida-
tion of a client-based clinical metrology instrument
for the evaluation of canine elbow osteoarthritis.
J Small Anim Pract 2009;50:266–271.
Hielm-Bjorkman A, Roine J, Elo K, ̈ et al.An
un-commissioned randomized, placebo-controlled


double-blind study to test the effect of deep sea fish
oil as a pain reliever for dogs suffering from canine
OA. BMC Vet Res 2012;8:157.
Hielm-Bj ̈orkmanAK,RitaH,TulamoRM,Psychome-
tric testing of the Helsinki chronic pain index by
completion of a questionnaire in Finnish by own-
ers of dogs with chronic signs of pain caused by
osteoarthritis. Am J Vet Res 2009;70:727–734.
Imhoff DJ, Gordon-Evans WJ, Evans RB,et al.Evalua-
tion of S-adenosyl-methionine in a double-blinded,
randomized, placebo-controlled, clinical trial for
treatment of presumptive osteoarthritis in the dog.
Vet Surg 2011;40: 228–232.
Lascelles BD, Knazovicky D, Case B,et al. A canine-
specific anti-nerve growth factor antibody alle-
viates pain and improves mobility and function
in dogs with degenerative joint disease-associated
pain. BMC Vet Res 2015;11:101.
McDowell I.Measuring Health: A guide to rating scales
and questionnaires. Oxford University Press, New
York, 2006.
Molsa SH, Hielm-Bj ̈ orkman AK, Laitinen-Vapaavuori ̈
OM. Use of an owner questionnaire to evaluate
long-term surgical outcome and chronic pain after
cranial cruciate ligament repair in dogs: 253 cases
(2004–2006). J Am Vet Med Assoc 2013;243:689–
695.
Patsopoulos NA. A pragmatic view on pragmatic tri-
als. Dialog Clin Neurosci 2011;13:217–224.
Rausch-Derra L, Huebner M, Wofford J, et al.
A prospective, randomized, masked, placebo-
controlled multisite clinical study of grapiprant,
an EP4 Prostaglandin Receptor Antagonist (PRA),
in dogs with osteoarthritis. J Vet Intern Med
2016;30:756–763.
Schulz KS, Cook JL, Kapatkin AS,et al. Evidence-
based surgery: time for change. Vet Surg 2006;35:
697–699. [Erratum appears in Vet Surg 2007;36:185].
Streiner DL, Norman GR.Health Measurement Scales:
A practical guide to their development and use. Oxford
UniversityPress, Oxford, 2014.
Sullivan MD, Bentley S, Fan MY,et al. A single-blind,
placebo run-in study of duloxetine for activity-
limiting osteoarthritis pain. J Pain 2009;10:208–213.
Sullivan MO, Gordon-Evans WJ, Knap KE,et al.Ran-
domized, controlled clinical trial evaluating the
efficacy of pulsed signal therapy in dogs with
osteoarthritis. Vet Surg 2013;42:250–254.
Walton MB, Cowderoy E, Lascelles D,etal. Evaluation
of construct and criterion validity for the ‘Liverpool
Osteoarthritis in Dogs’ (LOAD) clinical metrology
instrument and comparison to two other instru-
ments. PLoS One 2013;8:e58125.
Wucherer KL, Conzemius MG, Evans R,et al. Short-
term and long-term outcomes for overweight dogs
with cranial cruciate ligament rupture treated sur-
gically or nonsurgically. J Am Vet Med Assoc
2013;242:1364–1372.
Free download pdf